Teprotumumab for the treatment of thyroid eye disease: The Holy grail, really?

被引：1
|
作者：
Martel, A. [1 ]
机构：
[1] Cote Azur Univ, Univ Hosp Nice, Ophthalmol Dept, 30, voie Romaine, F-06000 Nice, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2023年 / 46卷 / 06期
关键词：
GRAVES ORBITOPATHY; RITUXIMAB;
D O I：
10.1016/j.jfo.2023.01.003
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：567 / 570
页数：4
相关论文
共 50 条
  • [21] Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
    Allen, Richard C.
    Bradley, Elizabeth A.
    Fante, Robert G.
    Lucarelli, Mark J.
    OPHTHALMOLOGY, 2021, 128 (08) : 1125 - 1128
  • [22] Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease
    Sears, Connie M.
    Azad, Amee D.
    Amarikwa, Linus
    Pham, Brandon H.
    Men, Clara J.
    Kaplan, Daniel N.
    Liu, Jocelyn
    Hoffman, Andrew R.
    Swanson, Austin
    Alyono, Jennifer
    Lee, Jennifer Y.
    Dosiou, Chrysoula
    Kossler, Andrea L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 240 : 1 - 13
  • [23] Successful Case of Teprotumumab Treatment in an Adolescent Patient With Thyroid Eye Disease
    Radulovich, Nicholas
    Van Brummen, Alexandra
    Chambers, Christopher
    Zhang, Matthew
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (02): : e65 - e67
  • [24] Correction: Teprotumumab: A Review in Thyroid Eye Disease
    Tina Nie
    Yvette N. Lamb
    Drugs, 2022, 82 : 1757 - 1757
  • [25] Improvement of asymmetric thyroid eye disease with teprotumumab
    Ugradar, Shoaib
    Wang, Yao
    Mester, Tunde
    Kahaly, George J.
    Douglas, Raymond
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (06) : 755 - 759
  • [26] Re: "Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease"
    Kan, Aaron Y. L.
    Tiong, Claudia J.
    Tsoi, Amy T.
    Vasanthan, Aadhavi
    Rezkalla, Mina
    Chan, Leo J. S.
    Francis, Ian C.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (05): : 582 - 583
  • [27] Percent reduction in proptosis after teprotumumab treatment for thyroid eye disease
    Rosenblatt, Tatiana R.
    Chiou, Carolina A.
    Yoon, Michael K.
    Lee, Nahyoung Grace
    Wolkow, Natalie
    Freitag, Suzanne K.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2024,
  • [28] Efficacy and Safety of Teprotumumab in Thyroid Eye Disease
    Teo, Honeylen Maryl
    Smith, Terry J.
    Joseph, Shannon S.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 1219 - 1230
  • [29] Teprotumumab for Optic Neuropathy in Thyroid Eye Disease
    Slentz, Dane H.
    Smith, Terry J.
    Kim, Denise S.
    Joseph, Shannon S.
    JAMA OPHTHALMOLOGY, 2021, 139 (02) : 244 - 247
  • [30] The knowns and unknowns of teprotumumab for thyroid eye disease
    Bednarczuk, Tomasz
    Pearce, Simon H.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (06): : 323 - 325
12345